Cargando…

The Experience of Oncology Healthcare Providers in the Central Italy during the COVID-19 Lockdown

SIMPLE SUMMARY: Few data in the literature are available about the psychological impact of COVID-19 pandemic on healthcare providers in Italy, especially with regards to different regions. In the present work, the “VIRARE” survey was addressed to all the healthcare providers in the Lazio region and,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fabi, Alessandra, Pugliese, Patrizia, Falbo, Pina Tiziana, Corsi, Domenico, Fabbri, Maria Agnese, Vincenzi, Bruno, Bria, Emilio, Angelini, Francesco, Bonucci, Alessandro, Pellegrino, Arianna, Falcicchio, Chiara, Caruso, Anita, Giacomelli, Luca, Mirisola, Valentina, Papa, Simonetta, Cognetti, Francesco, Ciliberto, Gennaro, Perrone, Maria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7603147/ https://www.ncbi.nlm.nih.gov/pubmed/33081044 http://dx.doi.org/10.3390/cancers12103031

Ejemplares similares

Use of rehabilitation pathways in women with breast cancer in the first 12 months of the disease: a retrospective study
por: Falcicchio, Chiara, et al.
Publicado: (2021)

The immersive experience of virtual reality during chemotherapy in patients with early breast and ovarian cancers: The patient’s dream study
por: Fabi, Alessandra, et al.
Publicado: (2022)

Liquid biopsy identifies actionable dynamic predictors of resistance to Trastuzumab Emtansine (T-DM1) in advanced HER2-positive breast cancer
por: Allegretti, Matteo, et al.
Publicado: (2021)

First-line therapy in HER2 positive metastatic breast cancer: is the mosaic fully completed or are we missing additional pieces?
por: Fabi, Alessandra, et al.
Publicado: (2016)

Tearing down the walls: FDA approves next generation sequencing (NGS) assays for actionable cancer genomic aberrations
por: Allegretti, Matteo, et al.
Publicado: (2018)

RANKL/RANK/OPG system beyond bone remodeling: involvement in breast cancer and clinical perspectives
por: Infante, Marco, et al.
Publicado: (2019)

Should All Patients With HR-Positive HER2-Negative Metastatic Breast Cancer Receive CDK 4/6 Inhibitor As First-Line Based Therapy? A Network Meta-Analysis of Data from the PALOMA 2, MONALEESA 2, MONALEESA 7, MONARCH 3, FALCON, SWOG and FACT Trials
por: Rossi, Valentina, et al.
Publicado: (2019)

Overview of Trop-2 in Cancer: From Pre-Clinical Studies to Future Directions in Clinical Settings
por: Lombardi, Pasquale, et al.
Publicado: (2023)

Magnitude of risks and benefits of the addition of bevacizumab to chemotherapy for advanced breast cancer patients: Meta-regression analysis of randomized trials
por: Cuppone, Federica, et al.
Publicado: (2011)

Targeting targeted agents: open issues for clinical trial design
por: Bria, Emilio, et al.
Publicado: (2009)

Precision Medicine and Melanoma: Multi-Omics Approaches to Monitoring the Immunotherapy Response
por: Valenti, Fabio, et al.
Publicado: (2021)

mTOR Cross-Talk in Cancer and Potential for Combination Therapy
por: Conciatori, Fabiana, et al.
Publicado: (2018)

Role of mTOR Signaling in Tumor Microenvironment: An Overview
por: Conciatori, Fabiana, et al.
Publicado: (2018)

Brain metastases from solid tumors: disease outcome according to type of treatment and therapeutic resources of the treating center
por: Fabi, Alessandra, et al.
Publicado: (2011)

Unusual phylogenetic tree and circulating actionable ESR1 mutations in an aggressive luminal/HER2-low breast cancer: Case report
por: Allegretti, Matteo, et al.
Publicado: (2023)

Reorganization of Istituti Fisioterapici Ospitalieri, an oncological and dermatological clinical and research center, to face the coronavirus health emergency: adopted measures and metrics of success to achieve and keep a COVID-19-free status
por: De Luca, Assunta, et al.
Publicado: (2020)

Anti-Oxidant and Anti-Inflammatory Activity of Ketogenic Diet: New Perspectives for Neuroprotection in Alzheimer’s Disease
por: Pinto, Alessandro, et al.
Publicado: (2018)

New perspectives in functional hypogonadotropic hypogonadism: beyond late onset hypogonadism
por: Spaziani, Matteo, et al.
Publicado: (2023)

Oligometastatic Breast Cancer: How to Manage It?
por: Barberi, Vittoria, et al.
Publicado: (2021)

The likelihood of being helped or harmed as a patient-centred tool to assess cyclin dependent kinase 4/6 inhibitors clinical impact and safety in metastatic breast cancer: a systematic review and sensitivity-analysis
por: Mastrantoni, Luca, et al.
Publicado: (2023)

The withdrawal from oncogenetic counselling and testing for hereditary and familial breast and ovarian cancer. A descriptive study of an Italian sample
por: Caruso, Anita, et al.
Publicado: (2008)

AXL Receptor in Breast Cancer: Molecular Involvement and Therapeutic Limitations
por: Falcone, Italia, et al.
Publicado: (2020)

Effects of Metformin With or Without Supplementation With Folate on Homocysteine Levels and Vascular Endothelium of Women With Polycystic Ovary Syndrome
por: Palomba, Stefano, et al.
Publicado: (2010)

The need for a national perspective to improve COPD management
por: Marco, Fabiano Di, et al.
Publicado: (2019)

Tumor Microenvironment and Microvascular Density in Follicular Lymphoma
por: Tamma, Roberto, et al.
Publicado: (2022)

Emerging therapeutics
por: Ciliberto, Gennaro
Publicado: (2021)

An Italian cost-effectiveness analysis of paclitaxel albumin (nab-paclitaxel) versus conventional paclitaxel for metastatic breast cancer patients: the COSTANza study
por: Lazzaro, Carlo, et al.
Publicado: (2013)

Single cell analysis to dissect molecular heterogeneity and disease evolution in metastatic melanoma
por: Fattore, Luigi, et al.
Publicado: (2019)

Treatment of recurrent malignant gliomas with fotemustine monotherapy: impact of dose and correlation with MGMT promoter methylation
por: Fabi, Alessandra, et al.
Publicado: (2009)

Subjective versus objective risk in genetic counseling for hereditary breast and/or ovarian cancers
por: Caruso, Anita, et al.
Publicado: (2009)

The clinician’s perspective on the 21-gene assay in early breast cancer
por: Cognetti, Francesco, et al.
Publicado: (2021)

Efficacy and safety of T-DM1 in the ‘common-practice’ of HER2+ advanced breast cancer setting: a multicenter study
por: Fabi, Alessandra, et al.
Publicado: (2017)

Alliance Against Cancer, the network of Italian cancer centers bridging research and care
por: De Paoli, Paolo, et al.
Publicado: (2015)

Pediatric Palliative Care: Insights into Assessment Tools and Review Instruments
por: Papa, Simonetta, et al.
Publicado: (2023)

Angiogenesis Inhibitors in NSCLC
por: Manzo, Anna, et al.
Publicado: (2017)

Early Treatment of Anterior Crossbite with Eruption Guidance Appliance: A Case Report
por: Pellegrino, Marianna, et al.
Publicado: (2020)

Does the Synergy Model Implementation Improve the Transition from In-Hospital to Primary Care? The Experience from an Italian Cardiac Surgery Unit, Perspectives, and Future Implications
por: Dellafiore, Federica, et al.
Publicado: (2022)

Maintenance bevacizumab beyond first-line paclitaxel plus bevacizumab in patients with Her2-negative hormone receptor-positive metastatic breast cancer: efficacy in combination with hormonal therapy
por: Fabi, Alessandra, et al.
Publicado: (2012)

Differential Response of Two Human Breast Cancer Cell Lines to the Phenolic Extract from Flaxseed Oil †
por: Sorice, Angela, et al.
Publicado: (2016)

Understanding the Drawbacks of the Current Tumor Staging Systems: How to Improve?
por: Giacomelli, Luca, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_qmn7tdmb4e6s8n77ouk8upgu7d